Open Access 01-12-2023 | NSCLC | Correction
Correction: Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in China
Published in: Health Economics Review | Issue 1/2023
Login to get access